Evolocumab in Patients at High Cardiovascular Risk Without P

Name: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
Uploaded: 2025-11-11T05:00:00+00:00
Description: This video brief features Dr. Lawrence Leiter reporting from AHA 2025 in New Orleans. He presents primary results from the landmark VESALIUS-CV trial

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Primary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
Primary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
Hyperlipidemia
Primary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
- Erin Bohula, MD, DPhil
Global Burden of Stroke and Myocardial Infarction in Patients at High Risk of First MACE: Insights From the VESALIUS-REAL Study
Global Burden of Stroke and Myocardial Infarction in Patients at High Risk of First MACE: Insights From the VESALIUS-REAL Study
Hyperlipidemia
Global Burden of Stroke and Myocardial Infarction in Patients at High Risk of First MACE: Insights From the VESALIUS-REAL Study
- Matthew Jay Budoff, MD
Evolocumab does not reduce vein graft failure after CABG
Evolocumab does not reduce vein graft failure after CABG
ESC Congress 2025
Evolocumab does not reduce vein graft failure after CABG
- Subodh Verma, MD, PhD
Adding AI-QCT enhances cardiovascular risk stratification
Adding AI-QCT enhances cardiovascular risk stratification
ESC Congress 2025
Adding AI-QCT enhances cardiovascular risk stratification
- Alexander van Rosendael, MD, PhD

Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial

Recommended

Title

Share on ReachMD

Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial 